Cocrystal Pharma (FRA:8CC) FFO


FRA:8CC Cocrystal Pharma Inc FRA:8CC
22 GF Score
Price €0.89
! 3 Warning Signs
View Full Analysis

What is Cocrystal Pharma FFO?

FFO (Funds from operations) only applies to REITs.

FRA:8CC
22GF Score
Cocrystal Pharma Inc FRA:8CC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cocrystal Pharma Business Description

Other Exchanges COCP:USA
Address 19805 North Creek Parkway, Bothell, WA, USA, 98011
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
22GF Score

Get the complete analysis for FRA:8CC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.89
Price